273 related articles for article (PubMed ID: 18048821)
1. Phase II study of uracil-tegafur with leucovorin in elderly (> or = 75 years old) patients with colorectal cancer: ECOG 1299.
Hochster HS; Luo W; Popa EC; Lyman BT; Mulcahy M; Beatty PA; Benson AB
J Clin Oncol; 2007 Dec; 25(34):5397-402. PubMed ID: 18048821
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
Shirao K; Hoff PM; Ohtsu A; Loehrer PJ; Hyodo I; Wadler S; Wadleigh RG; O'Dwyer PJ; Muro K; Yamada Y; Boku N; Nagashima F; Abbruzzese JL
J Clin Oncol; 2004 Sep; 22(17):3466-74. PubMed ID: 15277535
[TBL] [Abstract][Full Text] [Related]
3. Retrospective study of S-1 versus tegafur/uracil and oral leucovorin in patients with metastatic colorectal cancer.
Shibahara K; Yamamoto M; Kakeji Y; Sakata H; Maehara Y
Anticancer Res; 2008; 28(3B):1779-83. PubMed ID: 18630459
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of uracil/tegafur (UFT) plus oral Leucovorin (LV) therapy for colorectal cancer in elderly patients].
Mizushima T; Mizuno H; Ito T; Hoki M; Souma Y; Iwamoto T; Ozawa H; Kanou T; Nakamori Y; Iwase K
Gan To Kagaku Ryoho; 2006 Jul; 33(7):941-4. PubMed ID: 16835484
[TBL] [Abstract][Full Text] [Related]
5. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.
Lembersky BC; Wieand HS; Petrelli NJ; O'Connell MJ; Colangelo LH; Smith RE; Seay TE; Giguere JK; Marshall ME; Jacobs AD; Colman LK; Soran A; Yothers G; Wolmark N
J Clin Oncol; 2006 May; 24(13):2059-64. PubMed ID: 16648506
[TBL] [Abstract][Full Text] [Related]
6. UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer - a retrospective analysis.
Vormittag L; Kornek GV; Gruhsmann B; Lenauer A; Föger A; Depisch D; Lang F; Scheithauer W
Anticancer Drugs; 2007 Jul; 18(6):709-12. PubMed ID: 17762401
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of oral uracil/tegafur plus leucovorin in patients with hormone-refractory prostate carcinoma.
Bhandari MS; Pienta KJ; Fardig J; Olson K; Smith DC
Cancer; 2006 Apr; 106(8):1715-21. PubMed ID: 16534795
[TBL] [Abstract][Full Text] [Related]
8. Oral regimen consisting of UFT/UZEL for elderly patients with colorectal cancer.
Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Yamaki S; Asao T; Kuwano H
Hepatogastroenterology; 2006; 53(68):209-12. PubMed ID: 16608026
[TBL] [Abstract][Full Text] [Related]
9. Oral uracil-tegafur plus leucovorin vs fluorouracil bolus plus leucovorin for advanced colorectal cancer: a meta-analysis of five randomized controlled trials.
Bin Q; Li J; Liao C; Cao Y; Gao F
Colorectal Dis; 2011 Aug; 13(8):837-45. PubMed ID: 20050863
[TBL] [Abstract][Full Text] [Related]
10. Uracil-Tegafur and Oral Leucovorin Combined With Bevacizumab in Elderly Patients (Aged ≥ 75 Years) With Metastatic Colorectal Cancer: A Multicenter, Phase II Trial (Joint Study of Bevacizumab, Oral Leucovorin, and Uracil-Tegafur in Elderly Patients [J-BLUE] Study).
Nishina T; Moriwaki T; Shimada M; Higashijima J; Sakai Y; Masuishi T; Ozeki M; Amagai K; Negoro Y; Indo S; Denda T; Sato M; Yamamoto Y; Nakajima G; Mizuta M; Takahashi I; Hiroshima Y; Ishida H; Maeba T; Hyodo I
Clin Colorectal Cancer; 2016 Sep; 15(3):236-42. PubMed ID: 26778644
[TBL] [Abstract][Full Text] [Related]
11. Retrospectively comparative evaluation of the first- and second-line chemotherapy with campto and oxaliplatin combined with oral tegafur/uracil (UFT)/leucovorin (LV) in patients with metastatic colorectal cancer.
Hsiao SC; Lin JF; Chuang MT; Lee YA; Wu DL
Int Surg; 2009; 94(4):298-303. PubMed ID: 20302025
[TBL] [Abstract][Full Text] [Related]
12. A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer.
Xiong JP; Zhang L; Zhong LX; Qiu F; Xu J; Tao QS; Xiang XJ; Yu F; Tang XM
Anticancer Drugs; 2007 Oct; 18(9):1103-7. PubMed ID: 17704661
[TBL] [Abstract][Full Text] [Related]
13. A multiple-center phase II study of biweekly oxaliplatin and tegafur-uracil/leucovorin for chemonaive patients with advanced gastric cancer.
Chen JS; Rau KM; Chen YY; Huang JS; Yang TS; Lin YC; Liau CT; Lee KD; Su YC; Kao RH
Cancer Chemother Pharmacol; 2009 Apr; 63(5):819-25. PubMed ID: 18663448
[TBL] [Abstract][Full Text] [Related]
14. Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer.
Nogué M; Salud A; Batiste-Alentorn E; Saigí E; Losa F; Cirera L; Méndez M; Campos JM; Galan A; Escudero P; Arcusa A; Manzano H; de Mendizábal EV; de Olaguer JP; Boleda M; Guasch I; Vicente P
Eur J Cancer; 2005 Oct; 41(15):2241-9. PubMed ID: 16214045
[TBL] [Abstract][Full Text] [Related]
15. Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer.
Atasoy BM; Abacioglu U; Dane F; Ozgen Z; Yumuk PF; Ozden S; Akgun Z; Mayadagli A; Basaran G; Turhal S; Sengoz M
J BUON; 2007; 12(2):203-8. PubMed ID: 17600873
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of oxaliplatin and tegafur/uracil and oral folinic acid for advanced or metastatic colorectal cancer in elderly patients.
Rosati G; Cordio S; Tucci A; Blanco G; Bordonaro R; Reggiardo G; Manzione L
Oncology; 2005; 69(2):122-9. PubMed ID: 16118508
[TBL] [Abstract][Full Text] [Related]
17. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Tabe Y; Asao T; Kuwano H
Hepatogastroenterology; 2008; 55(85):1419-22. PubMed ID: 18795703
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of UFT plus oral leucovorin in advanced colorectal cancer: a multicenter study.
Thongprasert S; Maoleekoonpairoj S; Laohavinij S; Thavichaigarn P
J Med Assoc Thai; 2000 Jun; 83(6):676-80. PubMed ID: 10932496
[TBL] [Abstract][Full Text] [Related]
19. UFT as maintenance therapy in patients with advanced colorectal cancer responsive to the FOLFOX4 regimen.
Scalamogna R; Brugnatelli S; Tinelli C; Sagrada P; Gattoni E; Tronconi MC; Riccardi A; Luchena G; Corazza GR
Oncology; 2007; 72(5-6):267-73. PubMed ID: 18187947
[TBL] [Abstract][Full Text] [Related]
20. [Feasibility of weekday-on/weekend-off oral UFT/Leucovorin schedule as postoperative adjuvant chemotherapy for colorectal cancer].
Sadahiro S; Suzuki T; Maeda Y; Makuuchi H; Murayama C
Gan To Kagaku Ryoho; 2006 Mar; 33(3):333-6. PubMed ID: 16531713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
